FDA grants fast-track designation for Shire's lung drug
admin 13th September 2017 Uncategorised 0SHP607 targets chronic lung disease in premature infants
More: FDA grants fast-track designation for Shire's lung drug
Source: News
SHP607 targets chronic lung disease in premature infants
More: FDA grants fast-track designation for Shire's lung drug
Source: News
© 1994 - 2024 B.M. Pharmaceuticals